BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17847126)

  • 1. The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data.
    Morita S; Kaptein AA; Oba K; Sakamoto J
    Psychooncology; 2008 May; 17(5):474-9. PubMed ID: 17847126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
    Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
    Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
    Lagergren P; Fayers P; Conroy T; Stein HJ; Sezer O; Hardwick R; Hammerlid E; Bottomley A; Van Cutsem E; Blazeby JM;
    Eur J Cancer; 2007 Sep; 43(14):2066-73. PubMed ID: 17702567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
    Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
    Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
    Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pilot-testing of the Japanese version of the EORTC QLQ-STO22 gastric cancer module].
    Morita S; Shimozuma K; Sato A; Nakamachi M; Blazeby J; West K; Fukuhara S; Sakamoto J
    Gan To Kagaku Ryoho; 2004 Aug; 31(8):1195-9. PubMed ID: 15332542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
    Taphoorn MJ; Claassens L; Aaronson NK; Coens C; Mauer M; Osoba D; Stupp R; Mirimanoff RO; van den Bent MJ; Bottomley A;
    Eur J Cancer; 2010 Apr; 46(6):1033-40. PubMed ID: 20181476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
    Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
    Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EORTC QLQ-CX24 cervical cancer-specific quality of life questionnaire: psychometric properties in a South Asian sample of cervical cancer patients.
    Jayasekara H; Rajapaksa LC; Greimel ER
    Psychooncology; 2008 Oct; 17(10):1053-7. PubMed ID: 18203241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer quality of life questionnaire cervical cancer module.
    Shin DW; Ahn E; Kim YM; Kang S; Kim BG; Seong SJ; Cha SD; Park CY; Yun YH
    Oncology; 2009; 76(3):190-8. PubMed ID: 19209009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the polish version of the eortc QLQ-C30 and the QLQ-OG25 for the assessment of health-related quality of life in patients with esophagi-gastric cancer.
    Tomaszewski KA; Püsküllüoğlu M; Biesiada K; Bochenek J; Nieckula J; Krzemieniecki K
    J Psychosoc Oncol; 2013; 31(2):191-203. PubMed ID: 23514254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients.
    Chaukar DA; Das AK; Deshpande MS; Pai PS; Pathak KA; Chaturvedi P; Kakade AC; Hawaldar RW; D'Cruz AK
    Indian J Cancer; 2005; 42(4):178-84. PubMed ID: 16391435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
    Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
    Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery.
    Singer S; Wollbrück D; Wulke C; Dietz A; Klemm E; Oeken J; Meister EF; Gudziol H; Bindewald J; Schwarz R
    Head Neck; 2009 Jan; 31(1):64-76. PubMed ID: 18972411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of QOL questionnaires in Japan].
    Kobayashi K
    Gan To Kagaku Ryoho; 1999 Jan; 26(2 Suppl):189-95. PubMed ID: 9987518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.
    Cocks K; Cohen D; Wisløff F; Sezer O; Lee S; Hippe E; Gimsing P; Turesson I; Hajek R; Smith A; Graham L; Phillips A; Stead M; Velikova G; Brown J;
    Eur J Cancer; 2007 Jul; 43(11):1670-8. PubMed ID: 17574838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EORTC QLQ-INFO26: a questionnaire to assess information given to cancer patients a preliminary analysis in eight countries.
    Arraras JI; Kuljanic-Vlasic K; Bjordal K; Yun YH; Efficace F; Holzner B; Mills J; Greimel E; Krauss O; Velikova G;
    Psychooncology; 2007 Mar; 16(3):249-54. PubMed ID: 16858744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current developments in measuring quality of life with instruments of the European organisation for research and treatment of cancer (EORTC)].
    Singer S; Hofmeister D; Spiegel K; Boehm A
    Laryngorhinootologie; 2011 Oct; 90(10):591-4. PubMed ID: 22016255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.